Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center >> Industry news

Income, Lifestyle May Contribute to Disparity in Cancer Deaths

Income, Lifestyle May Contribute to Disparity in Cancer Deaths FRIDAY, Nov. 9, 2018 -- Socioeconomic and health-related behaviors contribute to county-level disparities in cancer deaths, according to a study published online Oct. 5 in JAMA Network Open.

FDA Approves Dsuvia

FDA Approves Dsuvia FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the developmen

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API) Audie

FDA Approves Hyrimoz

FDA Approves Hyrimoz FDA Approves Hyrimoz (adalimumab-adaz), a Biosimilar to Humira Holzkirchen, Germany, October 31, 2018 - Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced that the US Food and Drug Administ